Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine

Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine

Abstract Background The generation of induced pluripotent stem cells has opened the field of study for stem cell research, disease modeling and drug development. However, the epigenetic signatures present in somatic cells make cell reprogramming still an inefficient process. This epigenetic memory c...

Full description

Bibliographic Details
Main Authors:	Alain Aguirre-Vázquez, Fabiola Castorena-Torres, Beatriz Silva-Ramírez, Katia Peñuelas-Urquides, María Elena Camacho-Moll, Luis A. Salazar-Olivo, Iván Velasco, Mario Bermúdez de León
Format:	Article
Language:	English
Published:	BMC 2023-03-01
Series:	Stem Cell Research & Therapy
Subjects:	Hydralazine Valproic acid iPSC Fibroblasts Reprogramming Genes
Online Access:	https://doi.org/10.1186/s13287-023-03268-w

Similar Items

Generation of the induced pluripotent stem cell line UKWNLi005-A derived from a patient with the GLA mutation c.376A > G of unknown pathogenicity in Fabry disease
by: Maximilian Breyer, et al.
Published: (2022-05-01)

<i>Monodelphis domestica</i> Induced Pluripotent Stem Cells Reveal Metatherian Pluripotency Architecture
by: Satish Kumar, et al.
Published: (2022-10-01)

Co-expression networks in generation of induced pluripotent stem cells
by: Sharan Paul, et al.
Published: (2016-03-01)

Panobinostat Effectively Increases Histone Acetylation and Alters Chromatin Accessibility Landscape in Canine Embryonic Fibroblasts but Does Not Enhance Cellular Reprogramming
by: Maryam Moshref, et al.
Published: (2021-09-01)

Integrative Meta-Analysis during Induced Pluripotent Stem Cell Reprogramming Reveals Conserved Networks and Chromatin Accessibility Signatures in Human and Mouse
by: Chloe S. Thangavelu, et al.
Published: (2023-11-01)

Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts
by: Jin Seok Bang, et al.
Published: (2018-03-01)

Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
by: Abdallah Al‐Mohammad
Published: (2019-08-01)

Furosemide versus Hydralazine for Managing Post Partum Hypertension in Severe Preeclampsia: A Comparative Study
by: M Behrashi, et al.
Published: (2012-10-01)

EFFICACY OF HYDRALAZINE IN COMPARISON WITH LABETALOL FOR CONTROL OF SEVERE HYPERTENSION IN PATIENTS WITH ECLAMPSIA
by: Mehwish Syed, et al.
Published: (2020-08-01)

CtIP-Specific Roles during Cell Reprogramming Have Long-Term Consequences in the Survival and Fitness of Induced Pluripotent Stem Cells
by: Daniel Gómez-Cabello, et al.
Published: (2017-02-01)

5-Aza-2′-Deoxycytidine and Valproic Acid in Combination with CHIR99021 and A83-01 Induce Pluripotency Genes Expression in Human Adult Somatic Cells
by: Alain Aguirre-Vázquez, et al.
Published: (2021-03-01)

YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming
by: Giorgia Di Benedetto, et al.
Published: (2021-03-01)

LIF-activated Jak signaling determines Esrrb expression during late-stage reprogramming
by: Delun Huang, et al.
Published: (2018-01-01)

Diffuse hydralazine-associated vasculitis with pathergy: An overlapping picture of Sweet syndrome and bullous vasculitis
by: Sara Banbury, BA, et al.
Published: (2023-09-01)

Hydralazine-induced vasculitis presenting with ocular manifestations
by: Vivian S. Hawn, et al.
Published: (2022-06-01)

Comparison of the Efficacy of Nifedipine and Hydralazine in Hypertensive Crisis in Pregnancy
by: Zahra Rezaei, et al.
Published: (2011-11-01)

Comparison of the Efficacy of Nifedipine and Hydralazine in Hypertensive Crisis in Pregnancy
by: Yashar Youefzadeh-Fard, et al.
Published: (2011-11-01)

Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
by: Jin-he Jiang, et al.
Published: (2024-01-01)

Establishment of a transgene-free iPS cell line (SDQLCHi046-A) from a young patient bearing a HDAC8 mutation and suffering from Cornelia de Lange Syndrome
by: Zilong Li, et al.
Published: (2023-02-01)

Hierarchical Oct4 Binding in Concert with Primed Epigenetic Rearrangements during Somatic Cell Reprogramming
by: Jun Chen, et al.
Published: (2016-02-01)

An integration-free iPSC line SDQLCHi025-A from a girl with multiminicore disease carrying compound heterozygote mutations in RYR1 gene
by: Haiyan Zhang, et al.
Published: (2020-05-01)

Hydralazine inhibits ventricular tachyarrhythmias in an acquired long QT rabbit model
by: Kenta Tsutsui, MD, et al.
Published: (2014-06-01)

Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer
by: Nair Lopes, et al.
Published: (2021-08-01)

Hydralazine-induced pauci-immune glomerulonephritis: intriguing case series with misleading diagnoses
by: Faizan Babar, et al.
Published: (2016-04-01)

Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
by: Yang Zhou, et al.
Published: (2022-05-01)

Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage
by: Guang Yang, et al.
Published: (2018-09-01)

Comparison of the effect of two drug combinations of Labetalol-hydralazine and labetalol-trinitroglycerin on hemodynamic factors and bleeding volume during dacryocystorhinostomy
by: Seyed Morteza Heidari, et al.
Published: (2021-05-01)

Effect of Hydralazine on Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice
by: Yutang Wang, et al.
Published: (2023-11-01)

Profiling the role of m6A effectors in the regulation of pluripotent reprogramming
by: Wenjun Wang, et al.
Published: (2024-04-01)

Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues
by: Quentin Alle, et al.
Published: (2021-04-01)

Generation of Urine Cell-Derived Non-integrative Human iPSCs and iNSCs: A Step-by-Step Optimized Protocol
by: Lin Cheng, et al.
Published: (2017-10-01)

A non-integrated iPSC line (SDQLCHi042-A) from a boy suffering from familial combined hyperlipidemia with compound heterozygous mutations of lipoprotein lipase gene
by: Zilong Li, et al.
Published: (2021-05-01)

JAK/STAT3 regulated global gene expression dynamics during late-stage reprogramming process
by: Ling Wang, et al.
Published: (2018-03-01)

A Human Gonadal Cell Model From Induced Pluripotent Stem Cells
by: Daniel Rodríguez Gutiérrez, et al.
Published: (2018-10-01)

Evaluation of the Effect of Propofol–Remifentanil and Propofol–Hydralazine on the Bleeding Volume During Dacryocystorhinostomy Surgery Under General Anesthesia
by: Hamidreza Shetabi, et al.
Published: (2023-01-01)

Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
by: Sherida de Leeuw, et al.
Published: (2019-07-01)

Cardiomyocytes Derived from Induced Pluripotent Stem Cells as a Disease Model for Propionic Acidemia
by: Esmeralda Alonso-Barroso, et al.
Published: (2021-01-01)

Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene
by: Omer Hatim, et al.
Published: (2023-12-01)

Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes
by: Francis Grafton, et al.
Published: (2021-08-01)

Pluripotent Stem Cells for Spinal Cord Injury Repair
by: Maria Martin-Lopez, et al.
Published: (2021-11-01)